SoftMedx Healthcare Limited published its monthly return for the period ending 28 February 2026, reporting no changes in its authorized share capital. The total number of issued ordinary shares remained at 2,126.04 million, with zero treasury shares, mirroring the closing figures from the preceding month.

According to the announcement, the applicable public float requirement stands at 25.00%, and the company confirmed that it remains in compliance. There were no share options, warrants, convertibles, or other arrangements to issue new shares. All required confirmations and filings for the reporting period have been fulfilled in accordance with the relevant regulatory rules.